发明授权
US08802092B2 Mesothelioma therapeutic agent 有权
间皮瘤治疗剂

Mesothelioma therapeutic agent
摘要:
The present invention provides a mesothelioma therapeutic agent containing an interleukin-6 (IL-6) antagonist such as antibody to IL-6 receptor (IL-6R), and a mesothelioma cell growth inhibitor containing an IL-6 antagonist such as antibody to IL-6R.
公开/授权文献
信息查询
0/0